share_log

Amylyx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FONTEYNE PAUL R.

SEC ·  Jun 7 16:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more